JP2013525335A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013525335A5 JP2013525335A5 JP2013505489A JP2013505489A JP2013525335A5 JP 2013525335 A5 JP2013525335 A5 JP 2013525335A5 JP 2013505489 A JP2013505489 A JP 2013505489A JP 2013505489 A JP2013505489 A JP 2013505489A JP 2013525335 A5 JP2013525335 A5 JP 2013525335A5
- Authority
- JP
- Japan
- Prior art keywords
- emulsion
- emulsion according
- phospholipid
- polymer
- cellulose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000839 emulsion Substances 0.000 claims 21
- 150000003904 phospholipids Chemical class 0.000 claims 9
- 229920000642 polymer Polymers 0.000 claims 8
- 150000002632 lipids Chemical class 0.000 claims 4
- 238000000034 method Methods 0.000 claims 3
- 230000000087 stabilizing effect Effects 0.000 claims 3
- 239000008346 aqueous phase Substances 0.000 claims 2
- 239000001913 cellulose Substances 0.000 claims 2
- 229920002678 cellulose Polymers 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000007764 o/w emulsion Substances 0.000 claims 2
- 230000003204 osmotic effect Effects 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical group CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 claims 1
- 206010013774 Dry eye Diseases 0.000 claims 1
- 239000001856 Ethyl cellulose Substances 0.000 claims 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims 1
- 229920002683 Glycosaminoglycan Polymers 0.000 claims 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 230000007815 allergy Effects 0.000 claims 1
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 1
- 235000019325 ethyl cellulose Nutrition 0.000 claims 1
- 229920001249 ethyl cellulose Polymers 0.000 claims 1
- 208000030533 eye disease Diseases 0.000 claims 1
- 125000005456 glyceride group Chemical group 0.000 claims 1
- 229920002674 hyaluronan Polymers 0.000 claims 1
- 229960003160 hyaluronic acid Drugs 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 235000010445 lecithin Nutrition 0.000 claims 1
- 239000000787 lecithin Substances 0.000 claims 1
- 229940067606 lecithin Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229920000609 methyl cellulose Polymers 0.000 claims 1
- 239000001923 methylcellulose Substances 0.000 claims 1
- 235000010981 methylcellulose Nutrition 0.000 claims 1
- 239000012071 phase Substances 0.000 claims 1
- 150000003010 phosphonosphingolipids Chemical class 0.000 claims 1
- 150000003019 phosphosphingolipids Chemical class 0.000 claims 1
- 229920000136 polysorbate Polymers 0.000 claims 1
- 229940068965 polysorbates Drugs 0.000 claims 1
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1053030 | 2010-04-21 | ||
| FR1053030A FR2962044B1 (fr) | 2010-04-21 | 2010-04-21 | Emulsion lacrymimetique |
| PCT/EP2011/056447 WO2011131765A2 (fr) | 2010-04-21 | 2011-04-21 | Emulsion lacrymimetique |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013525335A JP2013525335A (ja) | 2013-06-20 |
| JP2013525335A5 true JP2013525335A5 (enExample) | 2014-06-05 |
| JP5917490B2 JP5917490B2 (ja) | 2016-05-18 |
Family
ID=43242426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013505489A Active JP5917490B2 (ja) | 2010-04-21 | 2011-04-21 | 人工涙エマルション |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9801899B2 (enExample) |
| EP (1) | EP2560616B1 (enExample) |
| JP (1) | JP5917490B2 (enExample) |
| DK (1) | DK2560616T3 (enExample) |
| ES (1) | ES2638868T3 (enExample) |
| FR (1) | FR2962044B1 (enExample) |
| HU (1) | HUE034442T2 (enExample) |
| PL (1) | PL2560616T3 (enExample) |
| PT (1) | PT2560616T (enExample) |
| WO (1) | WO2011131765A2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9278132B2 (en) * | 2012-02-13 | 2016-03-08 | Bausch & Lomb Incorporated | Ophthalmic pharmaceutical compositions and methods of making and using same |
| DE202014010412U1 (de) * | 2014-02-21 | 2015-09-01 | Ursapharm Arzneimittel Gmbh | Mikro- oder Nanoemulsion zur ophthalmologischen Anwendung |
| CN107864623A (zh) | 2015-05-21 | 2018-03-30 | 摩纳哥奥夫塔尔米斯公司 | 作为渗透压保护剂的硫辛酸和牛磺酸的组合 |
| RU2724955C2 (ru) * | 2015-05-21 | 2020-06-29 | Офтэлмис Монако | Офтальмологическая композиция, содержащая липоевую кислоту и мукомиметический полимер |
| ITUB20152542A1 (it) | 2015-07-28 | 2017-01-28 | Altergon Sa | Formulati oftalmici a base di complessi cooperativi di acido ialuronico a basso e alto peso molecolare |
| ES2621877B1 (es) * | 2016-01-04 | 2018-05-04 | Agencia Pública Empresarial Sanitaria Hospital De Poniente | Solución para resección endoscópica |
| EP3691654A4 (en) | 2017-09-25 | 2021-11-24 | Surface Pharmaceuticals, Inc. | OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT OF EYE SURFACE DISEASES |
| CA3124945A1 (en) | 2018-12-27 | 2020-07-02 | Surface Ophthalmics, Inc. | Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease |
| MX388336B (es) * | 2019-09-06 | 2025-03-19 | Sophia Holdings S A De C V | Composicion farmacéutica oftálmica, procesos de preparación y usos de las mismas |
| JPWO2021220712A1 (enExample) * | 2020-04-30 | 2021-11-04 | ||
| EP3919047A1 (en) * | 2020-06-03 | 2021-12-08 | AZAD Pharma AG | Microemulsion for the treatment of dry eye syndrome |
| WO2022240598A1 (en) | 2021-05-10 | 2022-11-17 | Surface Ophthalmics, Inc. | Use of chondroitin sulfate for relieving ocular pain |
| US12440510B2 (en) | 2021-05-10 | 2025-10-14 | Surface Ophthalmics, Inc. | Use of chondroitin sulfate for relieving ocular pain |
| WO2023073925A1 (ja) * | 2021-10-29 | 2023-05-04 | ロート製薬株式会社 | 眼科組成物 |
| FR3151481A1 (fr) * | 2023-07-28 | 2025-01-31 | Horus Pharma | Emulsion de type huile dans eau comprenant de l’acide hyaluronique et du dexpanthenol |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU614465B2 (en) * | 1989-04-05 | 1991-08-29 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Medicinal emulsions |
| DE4027320C2 (de) | 1990-08-29 | 1993-09-30 | Ursapharm Arzneimittel Gmbh | Fluid-Abgabeeinrichtung für keimfreies Fluid |
| JPH0623256A (ja) * | 1992-06-29 | 1994-02-01 | Nikko Kemikaruzu Kk | レシチンを利用した乳化剤及びo/w型エマルション |
| US5744155A (en) * | 1993-08-13 | 1998-04-28 | Friedman; Doron | Bioadhesive emulsion preparations for enhanced drug delivery |
| DE19527132A1 (de) * | 1995-07-25 | 1997-01-30 | Laevosan Gmbh & Co Kg | Ophthalmologische Ozonschutzzusammensetzung |
| JP3687277B2 (ja) * | 1997-06-10 | 2005-08-24 | サンスター株式会社 | 美白化粧料 |
| AU9281698A (en) * | 1997-10-01 | 1999-04-23 | Wakamoto Pharmaceutical Co., Ltd. | O/w emulsion compositions |
| FR2816600B1 (fr) | 2000-11-13 | 2003-03-21 | Michel Faurie | Dispositif distributeur de liquides goutte a goutte |
| DE10161110A1 (de) * | 2001-12-12 | 2003-06-26 | Ursapharm Arzneimittel Gmbh | Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung |
| DE10161149B4 (de) * | 2001-12-12 | 2007-03-08 | Ursapharm Arzneimittel Gmbh & Co. Kg | Verwendung von Heparin-haltigem Ophthalmikum |
| CA2498233C (en) * | 2002-09-09 | 2012-08-14 | Santen Pharmaceutical Co., Ltd. | Clear ophthalmic solution comprising latanoprost as active ingredient |
| FR2873358B1 (fr) | 2004-07-20 | 2006-11-10 | Sivel Soc Civ Ile | Dispositif de conditionnement et distribution d'un produit avec flacon filtre sterile muni d'un embout |
| JP5748385B2 (ja) * | 2006-01-13 | 2015-07-15 | 大正製薬株式会社 | O/w型エマルション水性点眼剤 |
| ITMI20060122A1 (it) * | 2006-01-25 | 2007-07-26 | Polichem Sa | Composizioni per uso vaginale |
| EP1834705B1 (de) | 2006-03-13 | 2011-09-14 | Ing. Erich Pfeiffer GmbH | Austragvorrichtung für ein fliessfähiges Medium |
| ITMO20060252A1 (it) | 2006-08-04 | 2008-02-05 | Mrp Medical Res & Promotion Es | Flacone per il contenimento di fluidi, particolarmente per prodotti farmaceutici o simili |
| US20100209364A1 (en) * | 2007-07-20 | 2010-08-19 | Rohto Pharmaceutical Co., Ltd. | Emulsified Composition |
| WO2009035033A1 (ja) * | 2007-09-14 | 2009-03-19 | Rohto Pharmaceutical Co., Ltd. | 眼科用組成物 |
| FR2921253B1 (fr) * | 2007-09-26 | 2012-11-16 | Lvmh Rech | Composition cosmetique sous la forme d'une emulsion comprenant une phase aqueuse continue et une phase grasse dispersee et son procede de preparation |
| JP5340954B2 (ja) * | 2007-11-16 | 2013-11-13 | テクノガード株式会社 | 薬物含有脂肪乳剤およびその製造方法 |
| FR2927064B1 (fr) | 2008-02-04 | 2010-03-26 | Rexam Pharma | Embout de distribution de liquide, et ensemble de conditionnement et des distribution de liquide comprenant un tel embout. |
| DE102008027146B4 (de) | 2008-06-02 | 2012-01-19 | Ing. Erich Pfeiffer Gmbh | Austragvorrichtung |
| US20100303915A1 (en) * | 2009-06-02 | 2010-12-02 | Abbott Medical Optics Inc. | Therapeutic opthalmic emulsions |
| WO2011115700A2 (en) * | 2010-03-18 | 2011-09-22 | Precision Dermatology, Inc. | Emollient foams for treatment of seborrheic dermatitis |
| EP2377508B1 (de) * | 2010-04-14 | 2012-10-17 | PM-International AG | Kosmetische O/W-Emulsion zur Hautpflege |
-
2010
- 2010-04-21 FR FR1053030A patent/FR2962044B1/fr active Active
-
2011
- 2011-04-21 EP EP11715556.4A patent/EP2560616B1/fr active Active
- 2011-04-21 JP JP2013505489A patent/JP5917490B2/ja active Active
- 2011-04-21 WO PCT/EP2011/056447 patent/WO2011131765A2/fr not_active Ceased
- 2011-04-21 DK DK11715556.4T patent/DK2560616T3/en active
- 2011-04-21 ES ES11715556.4T patent/ES2638868T3/es active Active
- 2011-04-21 US US13/642,580 patent/US9801899B2/en active Active
- 2011-04-21 HU HUE11715556A patent/HUE034442T2/en unknown
- 2011-04-21 PT PT117155564T patent/PT2560616T/pt unknown
- 2011-04-21 PL PL11715556T patent/PL2560616T3/pl unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013525335A5 (enExample) | ||
| JP5859976B2 (ja) | 眼科用エマルジョン | |
| RU2017146716A (ru) | Способ образования наночастиц циклоспорина а/ циклодекстрина | |
| JP6527468B2 (ja) | ヒアルロン酸ナトリウムとカルボキシメチルセルロースを含む人工涙液 | |
| JP2015531344A5 (enExample) | ||
| JP2013534244A5 (enExample) | ||
| JP6353365B2 (ja) | 水性液剤 | |
| NZ725028A (en) | Membrane-adherent self-assembled systems for treatment of ocular disorders | |
| JP2016153879A (ja) | コンタクトレンズ用眼科組成物 | |
| MX349169B (es) | Composiciones farmaceuticas oftalmicas y metodos para elaborar y usar las mismas. | |
| JP5627294B2 (ja) | コンタクトレンズ用眼科組成物 | |
| EA201300314A1 (ru) | Композиции и лекарственное средство для лечения глазных болезней, устройство, содержащее композиции и лекарственное средство | |
| JP2012189993A (ja) | コンタクトレンズ用液体組成物 | |
| JP2011132227A5 (enExample) | ||
| JPWO2007125731A1 (ja) | ソフトコンタクトレンズ用溶液及びそれを用いて得られる薬剤徐放性ソフトコンタクトレンズ並びにその製造方法 | |
| WO2010010689A1 (ja) | コンタクトレンズ用液剤 | |
| RU2013141546A (ru) | Применение вязкоэластичной жидкости для получения медицинского продукта для хирургического лечения глаз | |
| RU2670100C2 (ru) | Офтальмическая композиция для цвиттерионных мягких контактных линз | |
| JP4981181B1 (ja) | コンタクトレンズ用組成物 | |
| JP5398452B2 (ja) | 点眼剤 | |
| JP2016522257A5 (enExample) | ||
| TW201722437A (zh) | 眼科組成物 | |
| JP2017119693A (ja) | 眼科用組成物及びその製造方法 | |
| JP2012056875A (ja) | ソフトコンタクトレンズ用眼科組成物 | |
| CN105555268B (zh) | 阴离子性软隐形眼镜用眼科用组合物 |